The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

(HealthDay News) — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...

The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical ...

With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) ...

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.

Mayo Clinic Jacksonville supports a blood test for to diagnose Alzheimer's while Baptist Health implanted its first atrial ...

With faster scanning capabilities, the new machine allows the health center to serve more patients in need of cancer screening.